Korro Bio, Inc. (KRRO)
NASDAQ: KRRO · Real-Time Price · USD
15.94
-1.46 (-8.37%)
Mar 31, 2025, 10:51 AM EDT - Market open
Korro Bio Stock Forecast
KRRO's stock price has decreased by -80.3% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 6 analysts with 12-month price forecasts for Korro Bio stock have an average target of 132.17, with a low estimate of 95 and a high estimate of 180. The average target predicts an increase of 729.17% from the current stock price of 15.94.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Korro Bio stock from 7 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 3 | 3 | 3 | 3 | 3 |
| Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 7 | 7 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $115 | Strong Buy | Reiterates | $115 | +621.46% | Mar 20, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $105 → $95 | Buy | Maintains | $105 → $95 | +495.98% | Mar 19, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $115 | Strong Buy | Reiterates | $115 | +621.46% | Nov 22, 2024 |
| Jones Trading | Jones Trading | Strong Buy Initiates $130 | Strong Buy | Initiates | $130 | +715.56% | Nov 18, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $115 | Strong Buy | Reiterates | $115 | +621.46% | Nov 13, 2024 |
Financial Forecast
Revenue This Year
n/a
from 2.27M
Revenue Next Year
n/a
EPS This Year
-10.93
from -9.37
EPS Next Year
-10.36
from -10.93
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | n/a | n/a | n/a | ||
| Avg | n/a | n/a | n/a | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -9.12 | -5.92 | -6.62 | ||
| Avg | -10.93 | -10.36 | -11.73 | ||
| Low | -11.71 | -14.83 | -13.35 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.